这是一则更正通知, 查看更正后的实验方案。

Correction Notice: An Optimized Tat/Rev Induced Limiting Dilution Assay for the Characterization of HIV-1 Latent Reservoirs

更正:一种优化的 Tat/Rev 诱导的限制稀释测定表征 HIV-1 潜伏储库

 (*contributed equally to this work) 发布: 2022年06月05日 DOI: 10.21769/BioProtoc.4448 浏览次数: 535

评审: Alessandro DidonnaNarayan SubramanianSalim Gasmi

download pdf 下载 PDF 下载 PDF
ask Q&A
引用
收藏
Cited by
Presubmission Inquiry

实验方案合集

专注于特定技术或应用的、详细的、经过同行评审的实验方案合集

Cancer Research
Immunology
Developmental Biology
Microbiology
Neuroscience
Cell Imaging - A Special Collection for Cell Bio 2023

I am writing regarding our manuscript ''An Optimized Tat/Rev Induced Limiting Dilution Assay for the Characterization of HIV-1 Latent Reservoirs (https://bio-protocol.org/e4391)" which was published in Volume: 12, Issue: 8 of the Bio-protocol.

There has been a small mistake in the name and catalog number of an enzyme. The name and catalog number of the enzyme have been mentioned as My TaqTM DNA Polymerase (Bioline, catalog number: BIO-21105), instead of My TaqTM HS DNA Polymerase (Bioline, catalog number: BIO-21111) in the materials and reagents section of the protocol.

Accordingly, we need to make correction as follows (in Materials and Reagents): My TaqTM HS DNA Polymerase (Bioline, catalog number: BIO-21111).

您对这篇实验方法有问题吗?

在此处发布您的问题,我们将邀请本文作者来回答。同时,我们会将您的问题发布到Bio-protocol Exchange,以便寻求社区成员的帮助。

0/150

tip 提问指南

+ 问题描述

写下详细的问题描述,包括所有有助于他人回答您问题的信息(例如实验过程、条件和相关图像等)。

post 发布问题
0 Q&A